-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On Ascentage Pharma Group with Overweight Rating, Announces Price Target of $48

Benzinga·11/05/2025 11:19:53
Listen to the news
Piper Sandler analyst Biren Amin initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Overweight rating and announces Price Target of $48.